1. Home
  2. PTGX vs CAAP Comparison

PTGX vs CAAP Comparison

Compare PTGX & CAAP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PTGX
  • CAAP
  • Stock Information
  • Founded
  • PTGX 2006
  • CAAP 1998
  • Country
  • PTGX United States
  • CAAP Luxembourg
  • Employees
  • PTGX N/A
  • CAAP N/A
  • Industry
  • PTGX Biotechnology: Pharmaceutical Preparations
  • CAAP Aerospace
  • Sector
  • PTGX Health Care
  • CAAP Consumer Discretionary
  • Exchange
  • PTGX Nasdaq
  • CAAP Nasdaq
  • Market Cap
  • PTGX 3.3B
  • CAAP 3.3B
  • IPO Year
  • PTGX 2016
  • CAAP 2018
  • Fundamental
  • Price
  • PTGX $51.07
  • CAAP $21.00
  • Analyst Decision
  • PTGX Strong Buy
  • CAAP Strong Buy
  • Analyst Count
  • PTGX 8
  • CAAP 2
  • Target Price
  • PTGX $70.13
  • CAAP $24.35
  • AVG Volume (30 Days)
  • PTGX 608.4K
  • CAAP 92.3K
  • Earning Date
  • PTGX 08-06-2025
  • CAAP 08-20-2025
  • Dividend Yield
  • PTGX N/A
  • CAAP N/A
  • EPS Growth
  • PTGX N/A
  • CAAP N/A
  • EPS
  • PTGX 0.80
  • CAAP 1.05
  • Revenue
  • PTGX $209,180,000.00
  • CAAP $1,858,038,000.00
  • Revenue This Year
  • PTGX N/A
  • CAAP $0.91
  • Revenue Next Year
  • PTGX $53.09
  • CAAP $12.63
  • P/E Ratio
  • PTGX $63.42
  • CAAP $19.96
  • Revenue Growth
  • PTGX N/A
  • CAAP 28.46
  • 52 Week Low
  • PTGX $33.31
  • CAAP $14.00
  • 52 Week High
  • PTGX $60.60
  • CAAP $22.13
  • Technical
  • Relative Strength Index (RSI)
  • PTGX 37.60
  • CAAP 61.33
  • Support Level
  • PTGX $52.03
  • CAAP $19.39
  • Resistance Level
  • PTGX $54.81
  • CAAP $20.56
  • Average True Range (ATR)
  • PTGX 2.11
  • CAAP 0.48
  • MACD
  • PTGX -0.52
  • CAAP 0.13
  • Stochastic Oscillator
  • PTGX 8.78
  • CAAP 99.38

About PTGX Protagonist Therapeutics Inc.

Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.

About CAAP Corporacion America Airports SA

Corporacion America Airports SA acquires, develops, and operates airport concessions. Its operating segments are geographically divided into Argentina, Italy, Brazil, Uruguay, Ecuador, and Armenia. The company generates a majority of its revenue from the Argentina segment. The firm's revenue is categorized into Aeronautical Revenue, Non-Aeronautical Revenue, Commercial Revenue, Construction Service Revenue, and Other Revenue.

Share on Social Networks: